Parodilol

This classification denotes a vasodilating agent with the molecular formula C23H27N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Q1O6G98Q8, chemically known as (- )-1-((2-indol-3-yl-1,1-dimethylethyl)amino)-3-(indol-4-yloxy)-2-propanol but generally known as parodilol, which bears US NIH Compound Identifier 3047816. European Medicines Agency schedules Parodilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09629MIG. The term PARODILOL is an International Non-Proprietary Name. PARODILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule parodilol under HS 29339990 and SITC 51577. As of Q4 2014, PARODILOL remains the US FDA Preferred Term for this commodity. Parodilol bears US NLM identifiers UMLS ID C1882292 and NCI Concept Code C66325. SMILES: OC(CNC(Cc1c2c([nH]c1)cccc2)(C)C)COc1c2c([nH]cc2)ccc1.